Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,169 | 476 | 97.7% |
| Education | $165.39 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,913 | 91 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $815.32 | 76 | $0 (2022) |
| ABBVIE INC. | $782.83 | 80 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $601.48 | 38 | $0 (2024) |
| Allergan, Inc. | $479.78 | 47 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $422.48 | 21 | $0 (2023) |
| ITI, Inc. | $394.88 | 26 | $0 (2023) |
| Lundbeck LLC | $359.11 | 17 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $340.51 | 17 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $299.46 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,563 | 103 | Otsuka America Pharmaceutical, Inc. ($272.87) |
| 2023 | $1,380 | 80 | Alkermes, Inc. ($348.12) |
| 2022 | $944.47 | 57 | Alkermes, Inc. ($336.36) |
| 2021 | $955.00 | 65 | AbbVie Inc. ($212.24) |
| 2020 | $755.40 | 55 | Sunovion Pharmaceuticals Inc. ($247.37) |
| 2019 | $398.92 | 34 | Alkermes, Inc. ($181.86) |
| 2018 | $662.16 | 44 | Alkermes, Inc. ($293.53) |
| 2017 | $675.92 | 41 | Alkermes, Inc. ($281.28) |
All Payment Transactions
479 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: CNS | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $110.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Neuropsychiatry | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: CNS | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 53 | 175 | $16,338 | $10,096 |
| 2022 | 3 | 100 | 344 | $36,454 | $18,005 |
| 2021 | 4 | 131 | 334 | $45,438 | $15,118 |
| 2020 | 3 | 170 | 331 | $44,524 | $10,848 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 31 | 138 | $12,878 | $8,651 | 67.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 37 | $3,460 | $1,445 | 41.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 45 | 160 | $15,895 | $10,509 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 127 | $15,240 | $5,191 | 34.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 57 | $5,319 | $2,306 | 43.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 42 | 137 | $16,440 | $6,457 | 39.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 20 | 50 | $7,368 | $2,833 | 38.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 32 | 54 | $6,480 | $2,440 | 37.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 12 | 12 | $3,000 | $1,902 | 63.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 81 | $12,150 | $1,486 | 12.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 51 | 99 | $11,880 | $3,898 | 32.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 91 | $12,483 | $3,323 | 26.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 32 | 104 | $15,560 | $1,845 | 11.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 21 | 37 | $4,602 | $1,783 | 38.7% |
About John Napoli, PHD
John Napoli, PHD is a Psychiatry healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225004997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Napoli, PHD has received a total of $7,335 in payments from pharmaceutical and medical device companies, with $1,563 received in 2024. These payments were reported across 479 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($7,169).
As a Medicare-enrolled provider, Napoli has provided services to 454 Medicare beneficiaries, totaling 1,184 services with total Medicare billing of $54,067. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Buffalo, NY
- Active Since 02/23/2006
- Last Updated 01/11/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225004997
Products in Payments
- ARISTADA (Drug) $1,327
- VRAYLAR (Drug) $1,258
- LATUDA (Drug) $815.32
- REXULTI (Drug) $701.98
- CAPLYTA (Drug) $661.53
- Aristada 441 mg (Drug) $554.93
- INGREZZA (Drug) $340.51
- AUSTEDO (Drug) $273.38
- FANAPT (Drug) $196.92
- TRINTELLIX (Drug) $161.61
- COBENFY (Drug) $146.65
- Azstarys (Drug) $109.06
- HETLIOZ (Drug) $102.54
- Auvelity (Drug) $94.34
- ABILIFY MAINTENA (Drug) $83.17
- SPRAVATO (Drug) $69.37
- Sunosi (Drug) $62.10
- Austedo XR (Drug) $49.18
- BRINTELLIX (Drug) $43.55
- APLENZIN (Drug) $32.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Buffalo
Dr. Wendy Weinstein, Md, MD
Psychiatry — Payments: $516,185
Qasim Jaffri, D.o, D.O
Psychiatry — Payments: $10,515
Dr. Subhdeep Virk, Md, MD
Psychiatry — Payments: $8,458
Dr. Jarod Masci, M.d, M.D
Psychiatry — Payments: $7,362
Dr. Irina Schwartz, M.d, M.D
Psychiatry — Payments: $4,649
Dr. Jeffery Grace, M.d, M.D
Psychiatry — Payments: $2,277